Dr. Reddy's Laboratories Dirección
Dirección controles de criterios 2/4
El CEO de Dr. Reddy's Laboratories' es Erez Israeli, nombrado en Apr 2018, tiene una permanencia de 6.08 años. posee directamente un 0.022% de las acciones de la empresa, con un valor de ₹230.22M. La antigüedad media del equipo directivo y de la junta directiva es de 6.1 años y 3.8 años, respectivamente.
Información clave
Erez Israeli
Chief Executive Officer (CEO)
₹195.4m
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | 6.2yrs |
| Participación del CEO | 0.02% |
| Permanencia media de la dirección | 6.2yrs |
| Promedio de permanencia en la Junta Directiva | 3.9yrs |
Actualizaciones recientes de la dirección
Recent updates
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00
May 26
Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
May 10With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case
May 06There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding
Apr 18Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 02Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?
Jan 19Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E
Jan 01Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Oct 03Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
Jun 24Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year
Jun 10Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
May 27Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00
May 13Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Mar 06These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Dec 05Is Dr. Reddy's Laboratories (NSE:DRREDDY) A Risky Investment?
Sep 28Do Dr. Reddy's Laboratories' (NSE:DRREDDY) Earnings Warrant Your Attention?
Aug 17Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Shares Could Be 33% Above Their Intrinsic Value Estimate
Jul 21Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹30.00
Jul 08Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Larger Dividend Than Last Year At ₹30.00
Jun 22Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ₹56b |
| Dec 31 2023 | n/a | n/a | ₹52b |
| Sep 30 2023 | n/a | n/a | ₹51b |
| Jun 30 2023 | n/a | n/a | ₹47b |
| Mar 31 2023 | ₹195m | n/a | ₹45b |
| Dec 31 2022 | n/a | n/a | ₹36b |
| Sep 30 2022 | n/a | n/a | ₹31b |
| Jun 30 2022 | n/a | n/a | ₹30b |
| Mar 31 2022 | ₹127m | n/a | ₹24b |
| Dec 31 2021 | n/a | n/a | ₹26b |
| Sep 30 2021 | n/a | n/a | ₹19b |
| Jun 30 2021 | n/a | n/a | ₹17b |
| Mar 31 2021 | ₹120m | n/a | ₹17b |
| Dec 31 2020 | n/a | n/a | ₹21b |
| Sep 30 2020 | n/a | n/a | ₹15b |
| Jun 30 2020 | n/a | n/a | ₹19b |
| Mar 31 2020 | ₹195m | ₹107m | ₹19b |
| Dec 31 2019 | n/a | n/a | ₹16b |
| Sep 30 2019 | n/a | n/a | ₹27b |
| Jun 30 2019 | n/a | n/a | ₹21b |
| Mar 31 2019 | ₹123m | n/a | ₹19b |
Compensación vs. Mercado: La compensación total de Erez($USD2.34M) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD946.25K).
Compensación vs. Ingresos: La compensación de Erez ha aumentado más de un 20% en el último año.
CEO
Erez Israeli (56 yo)
6.2yrs
Permanencia
₹195,380,000
Compensación
Mr. Erez Israeli, MBA has been Chief Executive Officer of Dr. Reddy's Laboratories Limited since August 1, 2019. Mr. Israeli served as Chief Operating Officer, Global Head Generics & PSAI Business and Memb...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Chairman | 38.2yrs | ₹187.71m | 13.08% ₹ 132.0b | |
| Chairman of the Board & Member of the Management Council | 31.4yrs | ₹115.40m | 13.62% ₹ 137.4b | |
| CEO & Member of the Management Council | 6.2yrs | ₹195.38m | 0.022% ₹ 224.8m | |
| CFO & Member of Management Council | 3.5yrs | ₹65.16m | sin datos | |
| CEO of API & Services & Member of Management Council | no data | ₹40.12m | sin datos | |
| CEO of Branded Markets - India & Emerging Countries and Member of Management Council | no data | ₹80.20m | sin datos | |
| EVP, Head of Corporate Communications | 7yrs | ₹63.42m | sin datos | |
| Executive VP | 6.8yrs | ₹61.42m | sin datos | |
| CEO of European Generics & Member of Management Council | no data | ₹91.63m | sin datos | |
| Deputy CFO & Member of the Management Council | no data | ₹47.20m | sin datos | |
| Global Head of Integrated Product Development Organisation & Member of the Management Council | no data | ₹48.35m | sin datos | |
| Global Head of Quality and Pharmacovigilance & Member of the Management Council | less than a year | sin datos | sin datos |
6.2yrs
Permanencia media
56.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de DRREDDY es experimentado (6 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Chairman | 38.2yrs | ₹187.71m | 13.08% ₹ 132.0b | |
| Chairman of the Board & Member of the Management Council | 31.4yrs | ₹115.40m | 13.62% ₹ 137.4b | |
| Lead Independent Director | 17yrs | ₹15.35m | 0.0065% ₹ 65.5m | |
| Member of the Scientific Advisory Board | no data | ₹8.36m | sin datos | |
| Independent Director | 1.8yrs | ₹10.95m | sin datos | |
| Additional Independent Director | 5.4yrs | ₹13.15m | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent & Non Whole-time Director | 5.7yrs | ₹15.30m | sin datos | |
| Additional Independent Director | 2.4yrs | ₹3.41m | sin datos | |
| Independent Director | 1.4yrs | sin datos | sin datos | |
| Additional Independent Director | 2.4yrs | ₹16.84m | sin datos | |
| Director | 1.1yrs | sin datos | sin datos |
3.9yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: La junta directiva de DRREDDY se considera experimentada (3.8 años de antigüedad promedio).